Pediatric dosing of antimicrobials: Difference between revisions
From IDWiki
Content deleted Content added
→Antibiotics: added first to third gen cephalosporins |
→Cephalosporins: added ceftaz and cefix |
||
| Line 125: | Line 125: | ||
| 25-100 mg/kg/day split qid |
| 25-100 mg/kg/day split qid |
||
|- |
|- |
||
| osteomyelitis (oral step-down) |
| [[osteomyelitis]] (oral step-down) |
||
| colspan=2 | |
| colspan=2 | |
||
| 100-150 mg/kg/day split qid |
| 100-150 mg/kg/day split qid |
||
| Line 161: | Line 161: | ||
| 100-200 mg/kg/day split q6-8h (max 6 g/day) |
| 100-200 mg/kg/day split q6-8h (max 6 g/day) |
||
|- |
|- |
||
| rowspan=3 | meningitis |
| rowspan=3 | [[meningitis]] |
||
| 0-7 days |
| 0-7 days |
||
| |
| |
||
| Line 180: | Line 180: | ||
| 50-75 mg/kg q24h (max 2 g/day) |
| 50-75 mg/kg q24h (max 2 g/day) |
||
|- |
|- |
||
| meningitis |
| [[meningitis]] |
||
| >1 month |
| >1 month |
||
| |
| |
||
| 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day) |
| 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day) |
||
|- |
|- |
||
| rowspan=2 | gonorrhea |
| rowspan=2 | [[gonorrhea]] |
||
| ≥9 years |
| ≥9 years |
||
| |
| |
||
| Line 193: | Line 193: | ||
| |
| |
||
| 50 mg/kg IM once (max 250 mg) |
| 50 mg/kg IM once (max 250 mg) |
||
|- |
|||
| rowspan=2 | [[Ceftazidime]] IM/IV |
|||
| usual dose |
|||
| colspan=2 | |
|||
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) |
|||
|- |
|||
| [[meningitis]] or [[cystic fibrosis]] |
|||
| colspan=2 | |
|||
| 200 mg/kg/day split q6-8h (max 6 g/day) |
|||
|- |
|||
| [[Cefixime]] PO |
|||
| usual dose |
|||
| colspan=2 | |
|||
| 8 mg/kg/day split q12-24h (max 400 mg/day) |
|||
|} |
|} |
||
Revision as of 01:17, 18 November 2019
Antibiotics
Penicillins
| Drug | Indication | Age | Weight | Usual dose |
|---|---|---|---|---|
| Penicillin G IV/IM | moderate to severe infections | 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day) | ||
| meningitis | 400,000 U/kg/day split q4h (max 24 MU/day) | |||
| Penicillin VK PO | mild to moderate infections | 25-50 mg/kg/day split q8-12h | ||
| rheumatic fever (treatment) | ≤ 27 kg | 300 mg PO bid x10 days | ||
| > 27 kg | 600 mg PO bid x 10 days | |||
| rheumatic fever (prophylaxis) | > 5 years | 300 mg PO bid | ||
| asplenia (prophylaxis) | 6 months to 5 years | 150 mg PO bid | ||
| > 5 years | 300 mg PO bid | |||
| Cloxacillin IV | methicillin-susceptible Staphylococcus aureus | 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day) | ||
| Cloxacillin PO | use cephalexin instead | |||
| Ampicillin IV | usual dose | neonates | 100-200 mg/kg/day split q6-8h | |
| infants and children | 100-200 mg/kg/day split q6h (max 2 g/dose) | |||
| meningitis | neonates | 300 mg/kg/day split q6-8h | ||
| infants and children | 300-400 mg/kg/day split q4-6h (max 2 g/dose) | |||
| Amoxicillin PO | usual dose | 40-50 mg/kg/day split q8h | ||
| Streptococcus pneumoniae | 80-90 mg/kg/day split q8h | |||
| Group A Streptococcus pharyngitis | 50 mg/kg once daily x10 days (max 1 g/dose) | |||
| Amoxicillin-clavulanic acid PO | usual dose | 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) | ||
| Streptococcus pneumoniae | 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) | |||
| Piperacillin-tazobactam IV | usual dose | 240-300 mg/kg/day (pip component) split q6-8h | ||
| Pseudomonas aeruginosa or cystic fibrosis | 400 mg/kg/day split q6h | |||
Cephalosporins
| Drug | Indication | Age | Weight | Usual dose |
|---|---|---|---|---|
| First generation | ||||
| Cefazolin IV/IM | usual dose | 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) | ||
| Cephalexin PO | usual dose | 25-100 mg/kg/day split qid | ||
| osteomyelitis (oral step-down) | 100-150 mg/kg/day split qid | |||
| Second generation | ||||
| Cefuroxime IV/IM | usual dose | 100-150 mg/kg/day split q8h (max 2 g/dose) | ||
| Cefuroxime azetil PO | poor bioavailability; not recommended | |||
| Cefprozil PO | usual dose | 15-30 mg/kg/day split bid (max 1 g/day) | ||
| Third generation | ||||
| Cefotaxime IV/IM | usual dose | 0-7 days | 50 mg/kg/dose q8h | |
| >7 days | 50 mg/kg/dose q8h | |||
| infants and children | 100-200 mg/kg/day split q6-8h (max 6 g/day) | |||
| meningitis | 0-7 days | 50 mg/kg/dose q8h | ||
| >7 days | 50 mg/kg/dose q6h | |||
| infants and children | 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day) | |||
| Ceftriaxone IM/IV | usual dose | >1 month | 50-75 mg/kg q24h (max 2 g/day) | |
| meningitis | >1 month | 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day) | ||
| gonorrhea | ≥9 years | 250 mg IM once | ||
| <9 years | 50 mg/kg IM once (max 250 mg) | |||
| Ceftazidime IM/IV | usual dose | 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) | ||
| meningitis or cystic fibrosis | 200 mg/kg/day split q6-8h (max 6 g/day) | |||
| Cefixime PO | usual dose | 8 mg/kg/day split q12-24h (max 400 mg/day) | ||